deCODEme disappoints, predicting diabetes, and more
Some recent posts from VentureBeat Life Sciences that might be worth your time:
1) Two pieces (here and here) on the latest “personal genomics” service, deCODEme. VentureBeat finds it underpowered and badly implemented;
2) Pieces on cutting-edge diagnostic tests that aim to predict whether you’ll get diabetes or develop Alzheimer’s disease;
3) A look at iMedix, a Health 2.0 site that won a Crunchie award. It tries to mix health-search with social community, but VentureBeat LifeSciences says it does neither particularly well.
Next Story: 23andMe’s European vacation and other personal-genomics notes
Previous Story: Livescribe, the pen with ears, gets big boost
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.